نتایج جستجو برای: viii

تعداد نتایج: 21094  

Journal: :The Journal of Cell Biology 1988
R Kapoor L Y Sakai S Funk E Roux P Bornstein E H Sage

A pepsin-resistant triple helical domain (chain 50,000 Mr) of type VIII collagen was isolated from bovine corneal Descemet's membrane and used as an immunogen for the production of mAbs. An antibody was selected for biochemical and tissue immunofluorescence studies which reacted both with Descemet's membrane and with type VIII collagen 50,000-Mr polypeptides by competition ELISA and immunoblott...

2011
J. T. Peltonen P. Virtanen M. Meschke J. V. Koski T. T. Heikkilä J. P. Pekola

2018
Bernd Tischer Renato Marino Mariasanta Napolitano

Objectives To gain insights into the usage of factor VIII (FVIII) products by patients diagnosed with moderate/severe hemophilia A, and to assess the impact and perceived importance of product storage. Methods In this study, 200 patients diagnosed with moderate or severe hemophilia A across seven countries participated. Data were collected via a 30-minute, face-to-face interview in six countr...

2000
K. Stucki S. K. Solanki U. Schühle

We present an analysis of 26 far-ultraviolet emission lines belonging to 19 atoms and ions observed on both sides of the boundary of polar coronal holes as well as other quiet Sun areas along the limb. The observations were made with the SUMER instrument (Solar Ultraviolet Measurements of Emitted Radiation) onboard the Solar and Heliospheric Observatory (SOHO). We compare line intensities, shif...

Journal: :Journal of clinical pathology 1969
A L Bloom J C Giddings B Bevan M Letton R J Drummond

Cryoprecipitate antihaemophilic factor concentrate was prepared from fresh and 24-hour-old blood by quick and slow thaw methods. Recovery of factor VIII was greater by the slow thaw method and there was less loss into the supernatant plasma. Cryoprecipitate produced from fresh blood contained more factor VIII than that produced from 24-hour-old blood so that the most potent concentrate was prod...

2003
Qinghan Xiao

....................................................................................................................................... i Executive summary ................................................................................................................... iii Sommaire....................................................................................................................

Journal: :Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2009
Hassan Mansouritorghabeh Zahra Rezaieyazdi Mahshid Bagheri

BACKGROUND: Combined factor V and VIII deficiency (CF5F8D) is a rare autosomal recessive disorder, with an estimated prevalence of about 1:100,000 in the Jewish population. Affected individuals have between 5 and 30% of normal levels of factor V and VIII, whereas the levels of other plasma proteins are not altered. This bleeding disorder has been treated by replacement therapy with plasma infus...

Journal: :Blood 1987
M M Eibl R Ahmad H M Wolf Y Linnau E Götz J W Mannhalter

In this study we investigated different aspects of monocyte functions following interaction of monocytes (Mo) with therapeutic concentrations of factor VIII (F VIII) concentrate. A short (one-hour) treatment of normal Mo with F VIII concentrates led to a significant (P less than 0.001) down modulation of Fc receptors expressed in the Mo plasma membrane. This down modulation was accompanied by a...

Journal: :Blood 1983
M E Mikaelsson N Forsman U M Oswaldsson

The possible role of Ca2+ as an essential constituent part of the human factor VIII complex has been investigated by stability studies, metal determinations, and gel filtration experiments. In citrated plasma, the factor VIII coagulant activity (VIII:C) deteriorated during storage in a biphasic manner. Collection of blood in heparin, instead of chelating anticoagulants, or neutralization of cit...

Journal: :Blood 2002
Christopher B Doering Cassandra D Josephson Heather N Craddock Pete Lollar

Fulminant hepatic failure (FHF) in humans produces a bleeding diathesis due in large part to a reduction in the biosynthesis of liver-derived coagulation factors. Remarkably, factor VIII procoagulant activity is elevated in most of these patients despite widespread liver cell death. FHF can be modeled in mice by administration of azoxymethane, the active ingredient found in cycad palm nuts. We ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید